Descrição

An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are around 80 different autoimmune disorders ranging in severity from mild to disabling, depending on which system of the body is under attack and to what degree. The global autoimmune disease diagnostics market is set to grow by US$ 2 bilhão durante 2021-2027, crescendo a uma taxa composta de crescimento anual (CAGR) de 5.1% durante o período de previsão, de acordo com a empresa de dados e análise StrategyHelix. Growing patient awareness levels concerning autoimmune diseases, presence of favorable government initiatives, improved laboratory automation, rise in the geriatric population and growing prevalence of obesity, type 1 diabetes and other chronic diseases are expected to boost the market growth in the coming years.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2017-2020 e previsão para 2027 covering key market aspects like sales value for autoimmune disease diagnostics. The global autoimmune disease diagnostics market is segmented on the basis of type, gender, tecnologia, and region. Por tipo, it is categorized into systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics. The localized autoimmune disease diagnostics segment held the largest market share in 2020. By gender, the autoimmune disease diagnostics market is divided into female, and male. The female segment accounted for the largest market share in 2020. Based on technology, the autoimmune disease diagnostics market is divided into enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, e outros.

The systemic autoimmune disease diagnostics market is further segmented into rheumatoid arthritis, psoriasis/psoriatic arthritis, systemic lupus erythematosus, multiple sclerosis, e outros. Entre eles, rheumatoid arthritis segment held the largest market share in 2020. The localized autoimmune disease diagnostics market is further segmented into inflammatory bowel disease, type 1 diabetes, thyroid, e outros. Entre estes, thyroid segment held the largest market share in 2020.

The report has profiled some of the key players of the market such as Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux Inc., Bio-Rad AbD Serotec Limited, Bristol Myers Squibb (BMS), EUROIMMUN AG (PerkinElmer Inc.), F. Hoffmann-La Roche AG, Immuno Concepts Inc., INOVA Diagnostics Inc., Siemens Healthineers AG, SQI Diagnostics Inc., Thermo Fisher Scientific Inc., Trinity Biotech plc (IMMCO Diagnostics Inc).

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the autoimmune disease diagnostics market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

Tipo: systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics
Gênero: female, and male
Tecnologia: enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, e outros
Região: América do Norte, Ásia-Pacífico, Europa, and Rest of the World (ROW)
Anos considerados: este relatório cobre o período 2017 para 2027

Principais benefícios para as partes interessadas

Get a comprehensive picture of the global autoimmune disease diagnostics market
Identificar estratégias regionais e prioridades estratégicas com base em dados e análises locais
Identifique setores de crescimento e tendências para investimento
Understand what the future of the global autoimmune disease diagnostics market looks like
Identifique o cenário competitivo e a janela de oportunidade

Índice

1. Definição de mercado
2. Metodologia de Pesquisa
3. Dados de mercado & Panorama
3.1 Valor de mercado
3.2 Previsão de valor de mercado
4. Autoimmune Disease Diagnostics Market by Type
4.1 Systemic Autoimmune Disease Diagnostics
4.2 Localized Autoimmune Disease Diagnostics
5. Autoimmune Disease Diagnostics Market by Gender
5.1 Female
5.2 Male
6. Autoimmune Disease Diagnostics Market by Technology
6.1 Enzyme-Linked Immunosorbent Assay (Elisa)
6.2 Indirect Immunofluorescence (Iif)
6.3 Immunoblot
6.4 Multiplex Immunoassays
6.5 Outros
7. Autoimmune Disease Diagnostics Market by Region
7.1 América do Norte
7.2 Ásia-Pacífico
7.3 Europa
7.4 Rest Of The World (Row)
8. Perfis de empresa
8.1 Abbott Laboratories
8.2 Beckman Coulter Inc. (Danaher Corporation)
8.3 Becton, Dickinson and Company
8.4 bioMerieux, Inc..
8.5 Bio-Rad AbD Serotec Limited
8.6 Bristol Myers Squibb (BMS)
8.7 EUROIMMUN AG (PerkinElmer, Inc.)
8.8 F. Hoffmann-La Roche AG
8.9 Immuno Concepts, Inc..
8.10 INOVA Diagnostics, Inc..
8.11 Siemens Healthineers AG
8.12 SQI Diagnostics, Inc..
8.13 Thermo Fisher Scientific Inc.
8.14 Trinity Biotech plc (IMMCO Diagnostics Inc)
9. Apêndice
9.1 Sobre StrategyHelix
9.2 Isenção de responsabilidade